Boston Sci Gives Update on the Measured Launch of Lotus Edge

The Marlborough, MA-based company said in its 3Q19 earnings call it remains on pace to open 150 Lotus Edge accounts within its first 12 months in the U.S. FDA greenlit the transcatheter aortic valve replacement device in April of this year.